Please login to the form below
European Society of Cardiology
This page shows the latest European Society of Cardiology news and features for those working in and with pharma, biotech and healthcare.
Risk calculator to prevent heart attacks and strokes in type 2 diabetes patients
The SCORE2-Diabetes risk calculator, published in the European Heart Journal, will help doctors estimate the risk of developing heart or circulatory disease across the next decade. ... Included in the new European Society of Cardiology Guidelines, the
Latest news
-
World Heart Day highlights actions to prevent and control cardiovascular disease
The pandemic has also resulted in a major disruption in cardiac services, with the European Society of Cardiology reporting a ‘doubling’ of waiting list deaths in the UK alone. ... Commenting on the campaign, Stella Kyriakides, the European
-
BHF announces drug combination could delay need for high-risk surgery in patients with Marfan syndrome
free from the threat of needing risky surgery or experiencing a potentially deadly aortic tear.”. ... The findings were presented at the European Society of Cardiology Congress in Barcelona and published in The Lancet.
-
Boehringer Ingelheim/Lilly’s empagliflozin is first drug to show clear benefit in heart failure
Results presented at the European Society of Cardiology Congress from the phase 3 trial demonstrated a 27% drop in hospitalisation risk. ... Results from the phase 3 EMPEROR-Preserved trial were presented on 27 August 2021 at the European Society of
-
AstraZeneca’s Forxiga approved in Japan for the treatment of CKD
Naoki Kashihara, the national coordinator of the trial in Japan and president of the Japanese Society of Nephrology, said: “DAPA-CKD is the landmark trial that demonstrated unprecedented risk reduction for ... of the drug at the European Society of
-
Lexicon Pharma announces strong CV data for first-in-class sotagliflozin at the European Society of Cardiology’s annual meeting
US-based Lexicon Pharmaceuticals has announced further analyses on the cardiovascular benefits of its first-in-class candidate, sotagliflozin, at the European Society of Cardiology annual meeting. ... launched. Professor of Cardiology at the Université
More from news
Approximately 2 fully matching, plus 51 partially matching documents found.
Latest Intelligence
-
Improving cardiovascular disease care and awareness
Organisations such as the European Society of Cardiology are looking to support the development of national strategies such as those from NHS England on secondary prevention and recently, more pharma companies ... Scott Curley is general manager of Amarin
-
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
The European Society of Cardiology (ESC) saw its figures rocket, as did countless other conferences and symposia that were forced into a virtual existence by the pandemic’s rolling lockdowns. ... This year’s big conferences are, for now, still
-
Is it possible to change behaviour virtually?
One of my colleagues, Emma, has also incorporated virtual technology into a medical education programme. ... What value did the virtual mannequin add? It was the first time ever a virtual mannequin had been used at the European Society of Cardiology (ESC)
-
Helping European cardiologists keep up to date
But when asked about their propensity to take part in programmes in relation to: (1) the sponsoring organisation (independent bodies such as the European Society of Cardiology or an unrestricted grant ... In terms of the most valued forms of education,
-
Change drivers: multi-stakeholder education and collaboration
Professor John Camm, Chair of the European Society of Cardiology Committee for Guidelines on the Management of Atrial Fibrillation told me recently: “Well-meaning rewording of key messages to 'suit' different ... It resulted in improved cholesterol
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest from PMHub
-
Pharma conference trends and themes in the last two years
The European Society of Cardiology (ESC) found that in 2020 they had a 117% increase in attendance on the previous year, with 77, 350 virtual attendees in 2020 compared to 27, ... 1. The European Respiratory Society also noticed an increase in attendance
-
Conference research case study
Communication strategies and marketing messages were to be crafted using the outcomes data which our client planned to launch at the European Society of Cardiology (ESC) annual congress. ... meant to our clients key customers and the overall impact of
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
